Last update 08 May 2025

PD-1 x ENPP1 x PARP

Basic Info

Related Targets
PD-1ENPP1PARP

Related

1
Drugs associated with PD-1 x ENPP1 x PARP
AVA-NP-695
Target
ENPP1 x PARP x PD-1
Mechanism
ENPP1 inhibitors [+2]
Active Org.
Avammune Therapeutics, Inc.Avammune Therapeutics, Inc.
 [+2]
Originator Org.
Avammune Therapeutics, Inc.Avammune Therapeutics, Inc.
Active Indication
Osteosarcoma [+2]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with PD-1 x ENPP1 x PARP
Login to view more data
100 Translational Medicine associated with PD-1 x ENPP1 x PARP
Login to view more data
0 Patents (Medical) associated with PD-1 x ENPP1 x PARP
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free